Tenax Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.7M | $6.0M | $5.6M |
| FY2022 | $1.9M | $3.4M | $2.1M |
| FY2023 | $3.6M | $11.7M | $9.8M |
| FY2024 | $4.7M | $96.7M | $94.9M |
| FY2025 | $7.2M | $104.2M | $97.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.7M | $6.0M | $5.6M |
| FY2022 | $1.9M | $3.4M | $2.1M |
| FY2023 | $3.6M | $11.7M | $9.8M |
| FY2024 | $4.7M | $96.7M | $94.9M |
| FY2025 | $7.2M | $104.2M | $97.6M |